\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	the\\ patient\\'s\\ skin\\ was\\ extremely\\ taut\\ with\\ marked\\,\\ non\\-pitting\\,\\ symmetric\\ induration\\ over\\ his\\ cheeks\\,\\ lateral\\ and\\ posterior\\ neck\\,\\ chest\\,\\ upper\\ back\\ and\\ shoulders\\ extending\\ down\\ the\\ upper\\ arms\\,\\ abdomen\\,\\ and\\ upper\\ anterior\\ and\\ lateral\\ thighs\\.\\ there\\ was\\ no\\ sharp\\ line\\ of\\ demarcation\\ noted\\ between\\ involved\\ and\\ uninvolved\\ areas\\.\\ there\\ was\\ no\\ tenderness\\,\\ and\\ he\\ maintained\\ full\\ range\\ of\\ motion\\.\\ his\\ hands\\,\\ buttocks\\,\\ and\\ lower\\ legs\\ were\\ spared\\.\\ also\\ noted\\ were\\ diffuse\\ follicular\\ papules\\ and\\ perifollicular\\ erythema\\ over\\ his\\ cheeks\\,\\ neck\\,\\ upper\\ back\\,\\ upper\\ arms\\,\\ and\\ upper\\ chest\\.\\ heart\\ sounds\\ were\\ normal\\.\\ speech\\ and\\ swallowing\\ was\\ normal\\.\\ \ \(0\)\
\-\ laboratory\\:\\ normal\\ fasting\\ glucose\\.\\ elevated\\ aso\\ titer\\;\\ documented\\ positive\\ beta\\-streptococcal\\ throat\\ culture\\.\\ normal\\ cbc\\ without\\ eosinophilia\\;\\ normal\\ electrolytes\\,\\ liver\\ enzymes\\,\\ bun\\,\\ creatinine\\.\\ normal\\ aldolase\\ and\\ creatinine\\ kinase\\.\\ normal\\ esr\\;\\ ana\\ negative\\.\\ serum\\ protein\\ electrophoresis\\ \\(spep\\)\\ normal\\ with\\ no\\ evidence\\ of\\ monoclonal\\ peaks\\.\\ normal\\ electrocardiogram\\.\ \(0\)\
\-\ histopathology\\:\\ incisional\\ biopsy\\,\\ left\\ posterior\\ upper\\ arm\\:\\ extremely\\ thickened\\ dermis\\ with\\ thick\\,\\ non\\-hyalinized\\ collagen\\ bundles\\ separated\\ by\\ large\\ interfascicular\\ spaces\\;\\ sweat\\ glands\\ were\\ seen\\ in\\ the\\ mid\\-dermis\\.\\ there\\ were\\ decreased\\ numbers\\ of\\ fibroblasts\\.\\ special\\ stains\\ for\\ mucin\\ \\(colloidal\\ iron\\)\\ revealed\\ evidence\\ of\\ increased\\ mucopolysaccharides\\.\\ findings\\ were\\ consistent\\ with\\ scleredema\\.\ \(0\)\
\-\ no\\ definitive\\ treatment\\ is\\ available\\ and\\ the\\ patient\\ was\\ monitored\\ clinically\\.\\ there\\ was\\ slight\\ softening\\ two\\ months\\ after\\ initial\\ presentation\\.\\ on\\ phone\\ contact\\ five\\ months\\ later\\,\\ the\\ patient\\ reported\\ no\\ worsening\\,\\ but\\ no\\ significant\\ improvement\\.\ \(0\)\
\-\ scleredema\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#23\\)\\ presented\\ by\\:\\ jay\\ l\\.\\ viernes\\,\\ maj\\,\\ usaf\\,\\ mc\\,\\ fs\ \(0\)\
\-\ presented\\ complaining\\ of\\ a\\ two\\ month\\ history\\ of\\ increasing\\ tightness\\ of\\ his\\ skin\\ overlying\\ his\\ cheeks\\,\\ neck\\,\\ chest\\,\\ shoulders\\,\\ back\\,\\ upper\\ arms\\,\\ abdomen\\,\\ and\\ thighs\\.\\ he\\ reported\\ no\\ involvement\\ of\\ his\\ hands\\,\\ lower\\ legs\\ and\\ feet\\.\\ he\\ had\\ been\\ able\\ to\\ continue\\ performing\\ regular\\ physical\\ fitness\\ activities\\,\\ but\\ was\\ noting\\ increasing\\ difficulty\\ due\\ to\\ the\\ tightening\\ around\\ his\\ shoulders\\ and\\ neck\\.\\ the\\ patient\\ reported\\ having\\ a\\ history\\ of\\ infectious\\ mononucleosis\\ followed\\ by\\ a\\ beta\\ hemolytic\\ strep\\ throat\\ infection\\ approximately\\ six\\ to\\ eight\\ weeks\\ before\\ noting\\ his\\ skin\\ tightening\\.\\ the\\ patient\\ was\\ otherwise\\ healthy\\.\\ he\\ denied\\ any\\ family\\ history\\ of\\ diabetes\\ or\\ connective\\ tissue\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ his\\:\\ 0\\.24000819060221465\ \(0\)\
\-\ upper\\:\\ 0\\.21147857885783072\ \(0\)\
\-\ cheeks\\:\\ 0\\.19545855411643984\ \(0\)\
\-\ normal\\:\\ 0\\.1817763128842666\ \(0\)\
\-\ shoulders\\:\\ 0\\.16005171059297127\ \(0\)\
\-\ scleredema\\:\\ 0\\.15821953966039196\ \(0\)\
\-\ and\\:\\ 0\\.1533287062002534\ \(0\)\
\-\ were\\:\\ 0\\.15299530680050893\ \(0\)\
\-\ tightening\\:\\ 0\\.1511872168752388\ \(0\)\
\-\ arms\\:\\ 0\\.14972653905720176\ \(0\)\
\-\ was\\:\\ 0\\.13792012431247916\ \(0\)\
\-\ thighs\\:\\ 0\\.12446998142365227\ \(0\)\
\-\ noting\\:\\ 0\\.12215403404344968\ \(0\)\
\-\ neck\\:\\ 0\\.12104327544574656\ \(0\)\
\-\ he\\:\\ 0\\.11717205440328876\ \(0\)\
\-\ no\\:\\ 0\\.11260454332810599\ \(0\)\
\-\ dermis\\:\\ 0\\.11183952791044861\ \(0\)\
\-\ skin\\:\\ 0\\.11039822331782634\ \(0\)\
\-\ reported\\:\\ 0\\.1068872339490873\ \(0\)\
\-\ of\\:\\ 0\\.10648690902082875\ \(0\)\
\-\ beta\\:\\ 0\\.10274225839256\ \(0\)\
\-\ extremely\\:\\ 0\\.1013812590902235\ \(0\)\
\-\ creatinine\\:\\ 0\\.10073882112547691\ \(0\)\
\-\ throat\\:\\ 0\\.0992297095478452\ \(0\)\
\-\ back\\:\\ 0\\.0989743598573663\ \(0\)\
\-\ legs\\:\\ 0\\.09731585027559683\ \(0\)\
\-\ hands\\:\\ 0\\.09381193235518734\ \(0\)\
\-\ patient\\:\\ 0\\.0804469482649304\ \(0\)\
\-\ interfascicular\\:\\ 0\\.07910976983019598\ \(0\)\
\-\ the\\:\\ 0\\.0789649368748998\ \(0\)\
\-\ there\\:\\ 0\\.07873232490640401\ \(0\)\
\-\ chest\\:\\ 0\\.0783348232960854\ \(0\)\
\-\ increasing\\:\\ 0\\.07791993064473601\ \(0\)\
\-\ taut\\:\\ 0\\.0755936084376194\ \(0\)\
\-\ perifollicular\\:\\ 0\\.0755936084376194\ \(0\)\
\-\ aso\\:\\ 0\\.0755936084376194\ \(0\)\
\-\ aldolase\\:\\ 0\\.0755936084376194\ \(0\)\
\-\ colloidal\\:\\ 0\\.0755936084376194\ \(0\)\
\-\ mucopolysaccharides\\:\\ 0\\.0755936084376194\ \(0\)\
\-\ viernes\\:\\ 0\\.0755936084376194\ \(0\)\
\-\ jay\\:\\ 0\\.07309885222737227\ \(0\)\
\-\ uninvolved\\:\\ 0\\.07116376897497033\ \(0\)\
\-\ demarcation\\:\\ 0\\.0695826908347957\ \(0\)\
\-\ softening\\:\\ 0\\.0695826908347957\ \(0\)\
\-\ phone\\:\\ 0\\.0695826908347957\ \(0\)\
\-\ fitness\\:\\ 0\\.0695826908347957\ \(0\)\
\-\ electrophoresis\\:\\ 0\\.06824590831464986\ \(0\)\
\-\ electrocardiogram\\:\\ 0\\.06824590831464986\ \(0\)\
\-\ induration\\:\\ 0\\.06708793462454855\ \(0\)\
\-\ fasting\\:\\ 0\\.06708793462454855\ \(0\)\
\-\ spep\\:\\ 0\\.06708793462454855\ \(0\)\
\-\ incisional\\:\\ 0\\.06708793462454855\ \(0\)\
\-\ eosinophilia\\:\\ 0\\.06606652944221911\ \(0\)\
\-\ fibroblasts\\:\\ 0\\.06606652944221911\ \(0\)\
\-\ kinase\\:\\ 0\\.0651528513721466\ \(0\)\
\-\ monoclonal\\:\\ 0\\.0651528513721466\ \(0\)\
\-\ peaks\\:\\ 0\\.0651528513721466\ \(0\)\
\-\ numbers\\:\\ 0\\.0651528513721466\ \(0\)\
\-\ titer\\:\\ 0\\.06432632902078783\ \(0\)\
\-\ usaf\\:\\ 0\\.06432632902078783\ \(0\)\
\-\ tightness\\:\\ 0\\.06432632902078783\ \(0\)\
\-\ mononucleosis\\:\\ 0\\.06432632902078783\ \(0\)\
\-\ by\\:\\ 0\\.06302068145672775\ \(0\)\
\-\ sweat\\:\\ 0\\.06223499071182614\ \(0\)\
\-\ hemolytic\\:\\ 0\\.06163668997957003\ \(0\)\
\-\ mucin\\:\\ 0\\.06107701702172484\ \(0\)\
\-\ fs\\:\\ 0\\.06107701702172484\ \(0\)\
\-\ strep\\:\\ 0\\.06107701702172484\ \(0\)\
\-\ maj\\:\\ 0\\.0605512850896602\ \(0\)\
\-\ abdomen\\:\\ 0\\.06036719465394901\ \(0\)\
\-\ bundles\\:\\ 0\\.060055611839395395\ \(0\)\
\-\ two\\:\\ 0\\.05875333244142716\ \(0\)\
\-\ buttocks\\:\\ 0\\.05871882931924956\ \(0\)\
\-\ spared\\:\\ 0\\.05871882931924956\ \(0\)\
\-\ electrolytes\\:\\ 0\\.05871882931924956\ \(0\)\
\-\ stains\\:\\ 0\\.05871882931924956\ \(0\)\
\-\ separated\\:\\ 0\\.05831541141796412\ \(0\)\
\-\ presented\\:\\ 0\\.05769362961365733\ \(0\)\
\-\ months\\:\\ 0\\.05758851509776738\ \(0\)\
\-\ ana\\:\\ 0\\.05756085562914826\ \(0\)\
\-\ history\\:\\ 0\\.05669868170889124\ \(0\)\
\-\ follicular\\:\\ 0\\.05653945044681882\ \(0\)\
\-\ papules\\:\\ 0\\.05653945044681882\ \(0\)\
\-\ enzymes\\:\\ 0\\.05653945044681882\ \(0\)\
\-\ special\\:\\ 0\\.05653945044681882\ \(0\)\
\-\ evidence\\:\\ 0\\.056155986558988805\ \(0\)\
\-\ performing\\:\\ 0\\.05562577237674631\ \(0\)\
\-\ eight\\:\\ 0\\.05534142162307094\ \(0\)\
\-\ over\\:\\ 0\\.05501253523005939\ \(0\)\
\-\ maintained\\:\\ 0\\.05479925002538754\ \(0\)\
\-\ iron\\:\\ 0\\.05454036748683649\ \(0\)\
\-\ contact\\:\\ 0\\.054288989856600474\ \(0\)\
\-\ activities\\:\\ 0\\.054288989856600474\ \(0\)\
\-\ physical\\:\\ 0\\.05364514565388266\ \(0\)\
\-\ monitored\\:\\ 0\\.05313101616649918\ \(0\)\
\-\ documented\\:\\ 0\\.05291688378041738\ \(0\)\
\-\ glands\\:\\ 0\\.05250385710139895\ \(0\)\
\-\ noted\\:\\ 0\\.05245550260151336\ \(0\)\
\-\ mc\\:\\ 0\\.05191901164106921\ \(0\)\
\-\ connective\\:\\ 0\\.05137112919628\ \(0\)\
\-\ posterior\\:\\ 0\\.05116044464354989\ \(0\)\
\-\ speech\\:\\ 0\\.05102420609425991\ \(0\)\
\-\ lower\\:\\ 0\\.050556192312614226\ \(0\)\
\-\ collagen\\:\\ 0\\.050213155506178705\ \(0\)\
\-\ swallowing\\:\\ 0\\.049908846352400595\ \(0\)\
\-\ histopathology\\:\\ 0\\.049908846352400595\ \(0\)\
\-\ seminar\\:\\ 0\\.04976060477648204\ \(0\)\
\-\ uniformed\\:\\ 0\\.04933050402024722\ \(0\)\
\-\ lateral\\:\\ 0\\.0490995583605966\ \(0\)\
\-\ but\\:\\ 0\\.048923801663218\ \(0\)\
\-\ 1997\\:\\ 0\\.048920730735008\ \(0\)\
\-\ sharp\\:\\ 0\\.048657925137798416\ \(0\)\
\-\ services\\:\\ 0\\.048529449884012775\ \(0\)\
\-\ continue\\:\\ 0\\.048529449884012775\ \(0\)\
\-\ dermatology\\:\\ 0\\.04840285024849263\ \(0\)\
\-\ culture\\:\\ 0\\.04791416203365727\ \(0\)\
\-\ glucose\\:\\ 0\\.04779617489364769\ \(0\)\
\-\ bun\\:\\ 0\\.04767977152152065\ \(0\)\
\-\ thick\\:\\ 0\\.04701237145141853\ \(0\)\
\-\ feet\\:\\ 0\\.04649293949857524\ \(0\)\
\-\ protein\\:\\ 0\\.0459080940382455\ \(0\)\
\-\ esr\\:\\ 0\\.04527217102998725\ \(0\)\
\-\ definitive\\:\\ 0\\.045185015311273516\ \(0\)\
\-\ diabetes\\:\\ 0\\.045185015311273516\ \(0\)\
\-\ spaces\\:\\ 0\\.045013288491436196\ \(0\)\
\-\ erythema\\:\\ 0\\.044761910861200176\ \(0\)\
\-\ complaining\\:\\ 0\\.044761910861200176\ \(0\)\
\-\ five\\:\\ 0\\.044679711942288036\ \(0\)\
\-\ denied\\:\\ 0\\.044679711942288036\ \(0\)\
\-\ six\\:\\ 0\\.04443768913606253\ \(0\)\
\-\ serum\\:\\ 0\\.044358492959914744\ \(0\)\
\-\ able\\:\\ 0\\.04338980478501709\ \(0\)\
\-\ slight\\:\\ 0\\.043319586417423506\ \(0\)\
\-\ improvement\\:\\ 0\\.043180832721025554\ \(0\)\
\-\ regular\\:\\ 0\\.04271196604857263\ \(0\)\
\-\ having\\:\\ 0\\.04264700753497471\ \(0\)\
\-\ symmetric\\:\\ 0\\.04239193264566892\ \(0\)\
\-\ overlying\\:\\ 0\\.04214414661665086\ \(0\)\
\-\ healthy\\:\\ 0\\.04196284549717493\ \(0\)\
\-\ thickened\\:\\ 0\\.041726860295622864\ \(0\)\
\-\ difficulty\\:\\ 0\\.041611232969047986\ \(0\)\
\-\ cbc\\:\\ 0\\.04127332316758391\ \(0\)\
\-\ clinically\\:\\ 0\\.04110918096085175\ \(0\)\
\-\ 23\\:\\ 0\\.040789933093617475\ \(0\)\
\-\ down\\:\\ 0\\.04018466975880605\ \(0\)\
\-\ before\\:\\ 0\\.039991952471863816\ \(0\)\
\-\ infectious\\:\\ 0\\.039803425024846927\ \(0\)\
\-\ involved\\:\\ 0\\.039664671328448975\ \(0\)\
\-\ arm\\:\\ 0\\.039483053779022205\ \(0\)\
\-\ around\\:\\ 0\\.039483053779022205\ \(0\)\
\-\ family\\:\\ 0\\.03891776611006033\ \(0\)\
\-\ with\\:\\ 0\\.038745649063125186\ \(0\)\
\-\ full\\:\\ 0\\.03866879433946433\ \(0\)\
\-\ line\\:\\ 0\\.03854693864334958\ \(0\)\
\-\ range\\:\\ 0\\.03838708303825698\ \(0\)\
\-\ motion\\:\\ 0\\.038347575357091025\ \(0\)\
\-\ sounds\\:\\ 0\\.038191320300531274\ \(0\)\
\-\ worsening\\:\\ 0\\.03777559306997284\ \(0\)\
\-\ marked\\:\\ 0\\.037414210738230626\ \(0\)\
\-\ to\\:\\ 0\\.03710055307855505\ \(0\)\
\-\ laboratory\\:\\ 0\\.03592207615741451\ \(0\)\
\-\ involvement\\:\\ 0\\.035803686318432656\ \(0\)\
\-\ later\\:\\ 0\\.035401604717483756\ \(0\)\
\-\ otherwise\\:\\ 0\\.035262405564760194\ \(0\)\
\-\ biopsy\\:\\ 0\\.0346751589079547\ \(0\)\
\-\ heart\\:\\ 0\\.03439580493979169\ \(0\)\
\-\ liver\\:\\ 0\\.03412516983834843\ \(0\)\
\-\ presentation\\:\\ 0\\.034052802900865264\ \(0\)\
\-\ elevated\\:\\ 0\\.033722853063471274\ \(0\)\
\-\ areas\\:\\ 0\\.03358520063331606\ \(0\)\
\-\ available\\:\\ 0\\.03356246950361203\ \(0\)\
\-\ extending\\:\\ 0\\.03353979780176588\ \(0\)\
\-\ followed\\:\\ 0\\.03340499838782434\ \(0\)\
\-\ initial\\:\\ 0\\.03318488705317234\ \(0\)\
\-\ positive\\:\\ 0\\.03259673485456925\ \(0\)\
\-\ revealed\\:\\ 0\\.03243576650177464\ \(0\)\
\-\ between\\:\\ 0\\.032141774923296645\ \(0\)\
\-\ any\\:\\ 0\\.031970048103459325\ \(0\)\
\-\ approximately\\:\\ 0\\.031564054256509086\ \(0\)\
\-\ tenderness\\:\\ 0\\.03102242900760627\ \(0\)\
\-\ diffuse\\:\\ 0\\.03102242900760627\ \(0\)\
\-\ decreased\\:\\ 0\\.03064136639755673\ \(0\)\
\-\ negative\\:\\ 0\\.030625172329327276\ \(0\)\
\-\ month\\:\\ 0\\.0300918301106691\ \(0\)\
\-\ infection\\:\\ 0\\.02988140922518613\ \(0\)\
\-\ weeks\\:\\ 0\\.02964701871304951\ \(0\)\
\-\ been\\:\\ 0\\.028820496361690737\ \(0\)\
\-\ significant\\:\\ 0\\.028561613823139678\ \(0\)\
\-\ due\\:\\ 0\\.028435014187619546\ \(0\)\
\-\ anterior\\:\\ 0\\.027619924825414206\ \(0\)\
\-\ consistent\\:\\ 0\\.02682257282694133\ \(0\)\
\-\ increased\\:\\ 0\\.026749830103082493\ \(0\)\
\-\ without\\:\\ 0\\.02609240084495913\ \(0\)\
\-\ tissue\\:\\ 0\\.02594968910501952\ \(0\)\
\-\ exam\\:\\ 0\\.0249021116295796\ \(0\)\
\-\ case\\:\\ 0\\.024852081177253016\ \(0\)\
\-\ large\\:\\ 0\\.024785819758278888\ \(0\)\
\-\ had\\:\\ 0\\.024646673160582052\ \(0\)\
\-\ findings\\:\\ 0\\.024414339902428014\ \(0\)\
\-\ after\\:\\ 0\\.023997637200795972\ \(0\)\
\-\ treatment\\:\\ 0\\.023564134547682875\ \(0\)\
\-\ seen\\:\\ 0\\.023289036311307524\ \(0\)\
\-\ also\\:\\ 0\\.023268232012604646\ \(0\)\
\-\ disease\\:\\ 0\\.020764822053493698\ \(0\)\
\-\ or\\:\\ 0\\.01720896426691377\ \(0\)\
\-\ left\\:\\ 0\\.01687454301110479\ \(0\)\
\-\ for\\:\\ 0\\.014993308343116707\ \(0\)\
\-\ on\\:\\ 0\\.01494012252159183\ \(0\)\
\-\ is\\:\\ 0\\.013547091138215629\ \(0\)\
\-\ in\\:\\ 0\\.012305981411046763\ \(0\)\
